Literature DB >> 22222271

Involvement of SPARC and MMP-3 in the pathogenesis of human pterygium.

Li-Fong Seet1, Louis Tong, Roseline Su, Tina T Wong.   

Abstract

PURPOSE: To investigate the expression of SPARC and matrix metalloproteinases (MMPs) in normal conjunctiva and pterygium tissues.
METHODS: This study involved paired control or uninvolved conjunctiva and pterygium tissue from 21 patients. Quantitative real-time PCR was performed to assess SPARC and MMP mRNA expression, whereas Western blot analysis was performed to assess SPARC protein levels in normal conjunctiva and pterygium tissue. Tissue localization of SPARC, extracellular matrix proteins, and MMPs were determined by immunofluorescence analyses.
RESULTS: SPARC transcript and protein levels were upregulated in pterygium compared with normal conjunctiva. Immunofluorescence analyses showed localization of SPARC to the epithelial basement membrane and stroma of normal conjunctiva tissue. Increased SPARC in the pterygium stroma colocalized partially with elevated collagen I, fibronectin, α-SMA, and MMP-3. SPARC and MMP-3 also colocalized in the pterygium epithelium.
CONCLUSIONS: SPARC was upregulated in pterygium and may collaborate with increased MMP-3 in some patients to account for many of the phenotypic properties characteristic of pterygium.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22222271     DOI: 10.1167/iovs.11-7941

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

Review 1.  Aberrant expression of genes and proteins in pterygium and their implications in the pathogenesis.

Authors:  Qing-Yang Feng; Zi-Xuan Hu; Xi-Ling Song; Hong-Wei Pan
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

Review 2.  The role of heredity in pterygium development.

Authors:  Peter Anguria; James Kitinya; Sam Ntuli; Trevor Carmichael
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

3.  Hyperglycemia-suppressed expression of Serpine1 contributes to delayed epithelial wound healing in diabetic mouse corneas.

Authors:  Haijing Sun; Xiaofan Mi; Nan Gao; Chenxi Yan; Fu-Shin Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 4.  Pterygium: an update on pathophysiology, clinical features, and management.

Authors:  Toktam Shahraki; Amir Arabi; Sepehr Feizi
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

5.  Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13.

Authors:  Yeoun-Hee Kim; Jae-Chang Jung; Sang Il Gum; Su-Bin Park; Jin Yeul Ma; Yong Il Kim; Kyoo Won Lee; Young Jeung Park
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

6.  Comparison of fibrin glue and Vicryl sutures in conjunctival autografting for pterygium surgery.

Authors:  Xiu Wang; Yan Zhang; Lei Zhou; Ruihua Wei; Lijie Dong
Journal:  Mol Vis       Date:  2017-04-19       Impact factor: 2.367

7.  Exploring the Molecular Mechanisms of Pterygium by Constructing lncRNA-miRNA-mRNA Regulatory Network.

Authors:  Nuo Xu; Yi Cui; Jiaxing Dong; Li Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

8.  Positive-charge tuned gelatin hydrogel-siSPARC injectable for siRNA anti-scarring therapy in post glaucoma filtration surgery.

Authors:  Yong Yao Chun; Zhu Li Yap; Li Fong Seet; Hiok Hong Chan; Li Zhen Toh; Stephanie W L Chu; Ying Shi Lee; Tina T Wong; Timothy T Y Tan
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

9.  Proteomic analysis in pterygium; upregulated protein expression of ALDH3A1, PDIA3, and PRDX2.

Authors:  Sun Woong Kim; Jonghoon Lee; Boram Lee; Taiyoun Rhim
Journal:  Mol Vis       Date:  2014-08-27       Impact factor: 2.367

10.  Activation of the Sphingosine 1 Phosphate-Rho Pathway in Pterygium and in Ultraviolet-Irradiated Normal Conjunctiva.

Authors:  Nozomi Igarashi; Megumi Honjo; Takashi Fujishiro; Tetsuya Toyono; Takashi Ono; Yosai Mori; Kazunori Miyata; Hideru Obinata; Makoto Aihara
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.